ACIC vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ACIC's Piotroski F-Score of 3/9 indicates weak financial health, with no Altman Z-Score available to assess bankruptcy risk. Despite a high Graham Number ($16.99) and strong profitability metrics like 31.85% profit margin and 38.61% ROE, the company exhibits severe revenue contraction (-23.50% YoY) and negative operating margin (-10.03%), signaling deteriorating core business performance. The stock trades at a P/E of 6.54, below sector average, but this is likely a reflection of declining fundamentals rather than undervaluation. Analysts recommend 'buy' with a $14.00 target, but insider selling and weak technical momentum undermine conviction.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
ACIC vs JPM: Head-to-Head Comparison
This page compares American Coastal Insurance Corporation (ACIC) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.